Saturday 17 October 2026
Export MNTK’s income statement to Excel — free account
Montauk Renewables, Inc.
MNTK Basic Materials Specialty Chemicals
Montauk Renewables, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.4 million, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 19.7%, EPS grew 104.0%, free cash flow grew 60.4% and total debt rose 114.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.14
0.02
+0.94%
Follow MNTK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
25.32 | 57.50 | 100.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.18 | 0.91 | 1.35 | 1.79 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
15.31 | 10.40 | 708.74 | 22.74 | |
P/B ratio |
0.84 | 0.62 | 0.91 | 1.10 | |
Price to Tangible BV |
0.91 | 0.67 | 0.98 | 1.19 | |
EV/Sales |
1.90 | 1.61 | 1.95 | 2.16 | |
EV/EBITDA |
10.36 | 9.28 | 11.01 | 16.63 | |
EV/Operating CF |
8.29 | 7.86 | 11.33 | 11.32 | |
EV/FCF |
(4.32) | (2.95) | (3.99) | (6.64) | |
Quick Ratio |
0.51 | 0.76 | 1.01 | 0.25 | |
Current Ratio |
0.62 | 0.85 | 1.11 | 0.33 | |
Net Debt/EBITDA |
16.39 | 17.86 | 15.47 | 4.65 | |
Debt/Assets |
31.79% | 31.96% | 29.56% | 17.41% | |
Debt/Equity |
0.57 | 0.57 | 0.49 | 0.26 | |
Asset Turnover |
0.44 | 0.44 | 0.45 | 0.42 | |
Operating CF/Net income |
64.60 | 3,169.20 | 0.14 | 2.43 | |
Capex/Depreciation |
(3.00) | (3.62) | (4.91) | (3.53) | |
Interest Coverage |
(0.05) | (1.20) | (1.29) | 4.14 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
67.99% | 67.14% | 64.93% | 53.00% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.96% | 1.37% | (0.02%) | 1.80% | |
Graham Net Nets |
(0.80) | (1.02) | (0.57) | (0.36) | |
Graham Number |
1.60 | 0.91 | 0.83 | 0.00 | |
Earnings Yield |
3.95% | 1.74% | 1.00% | (3.15%) | |
Free Cash Flow Yield |
(37.29%) | (59.92%) | (36.09%) | (18.21%) | |
Revenue per Share |
0.38 | 0.32 | 0.30 | 0.32 | |
Operating CF per Share |
0.10 | 0.11 | 0.00 | 0.09 | |
Capex per Share |
(0.17) | (0.22) | (0.29) | (0.21) | |
Free Cash Flow per Share |
(0.07) | (0.10) | (0.29) | (0.12) | |
Cash per Share |
0.11 | 0.18 | 0.17 | 0.05 | |
Shareholders Equity per Share |
1.85 | 1.84 | 1.84 | 1.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.85 | 1.84 | 1.84 | 1.82 | |
Free Cash Flow |
(10.09) | (14.99) | (41.10) | (17.16) | |
Working Capital |
(17.03) | (6.29) | 3.73 | (35.93) | |
Capital Expenditures |
(24.69) | (30.83) | (41.44) | (29.81) | |
Net Current Asset Value |
(178.87) | (168.32) | (135.16) | (104.61) | |
EV/EBIT |
320.63 | 0.00 | 403.55 | 0.00 | |
Capex to Sales |
0.46 | 0.66 | 0.95 | 0.66 | |
Price to Operating Income |
198.99 | 0.00 | 280.33 | 0.00 | |
| Other line items | |||||
Average Receivables |
7.53 | 7.34 | 9.04 | 12.98 | |
Average Payables |
26.51 | 21.93 | 12.25 | 17.79 | |
Average Assets |
426.60 | 411.00 | 392.24 | 378.71 | |
Average Common Equity |
259.62 | 260.98 | 260.28 | 268.03 |
Columns are period end dates